Literature DB >> 18201866

Evaluation of the Symptom Representation Questionnaire (SRQ) for assessing cancer-related symptoms.

Heidi Scharf Donovan1, Sandra Ward, Paula Sherwood, Ronald C Serlin.   

Abstract

Multidimensional, multisymptom approaches to cancer symptom assessment and management have been emphasized across health disciplines. However, each dimension that is assessed significantly increases patient/subject burden. Efficient, reliable, and valid assessment of the critical dimensions of patients' most salient symptoms is important in clinical and research settings. The Symptom Representation Questionnaire (SRQ), derived from information processing theory, assesses critical cognitive and emotional factors that are known to influence coping and outcomes. The SRQ was developed and evaluated in a three-phase process: (1) item selection, modification, and review by theoretical and clinical experts; (2) pilot evaluation of feasibility and psychometric properties; and (3) large sample psychometric evaluation. In Phase 3, members (n=713) of the National Ovarian Cancer Coalition participated via mailed surveys. Internal consistency was good for all subscales (alpha=0.63-0.88). The internal structure of the SRQ was theoretically consistent except that emotional representation, identity, and consequence items all loaded onto a single factor. Between-group comparisons supported construct validity: Representations differed between long-term survivors and women with active disease. Finally, there were significant correlations between SRQ subscales and Symptom Interference and Life Satisfaction. The SRQ appears to be a psychometrically sound instrument for assessing representations of cancer-related symptoms. This instrument could play an essential role in advancing knowledge of the relationships among representations of symptoms, symptom management processes, and symptom-related outcomes. It could also be used in intervention research when changes in symptom representations are hypothesized to mediate changes in outcomes as a result of psychoeducational interventions.

Entities:  

Mesh:

Year:  2008        PMID: 18201866      PMCID: PMC2408721          DOI: 10.1016/j.jpainsymman.2007.04.017

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  34 in total

1.  A randomized trial of a representational intervention to decrease cancer pain (RIDcancerPain).

Authors:  Sandra Ward; Heidi Donovan; Sigridur Gunnarsdottir; Ronald C Serlin; Gary R Shapiro; Susan Hughes
Journal:  Health Psychol       Date:  2008-01       Impact factor: 4.267

Review 2.  The middle-range theory of unpleasant symptoms: an update.

Authors:  E R Lenz; L C Pugh; R A Milligan; A Gift; F Suppe
Journal:  ANS Adv Nurs Sci       Date:  1997-03       Impact factor: 1.824

3.  Coping with epilepsy: do illness representations play a role?

Authors:  S Kemp; S Morley; E Anderson
Journal:  Br J Clin Psychol       Date:  1999-03

4.  Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia.

Authors:  Dónal G Fortune; Helen L Richards; Christopher E M Griffiths; Chris J Main
Journal:  Br J Clin Psychol       Date:  2002-06

Review 5.  Advancing the science of symptom management.

Authors:  M Dodd; S Janson; N Facione; J Faucett; E S Froelicher; J Humphreys; K Lee; C Miaskowski; K Puntillo; S Rankin; D Taylor
Journal:  J Adv Nurs       Date:  2001-03       Impact factor: 3.187

6.  Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.

Authors:  C S Cleeland; T R Mendoza; X S Wang; C Chou; M T Harle; M Morrissey; M C Engstrom
Journal:  Cancer       Date:  2000-10-01       Impact factor: 6.860

7.  Measuring symptom distress in patients with lung cancer. A pilot study of experienced intensity and importance of symptoms.

Authors:  C Tishelman; L F Degner; B Mueller
Journal:  Cancer Nurs       Date:  2000-04       Impact factor: 2.592

8.  Cholesterol control, medication adherence and illness cognition.

Authors:  Noel T. Brewer; Gretchen B. Chapman; Susan Brownlee; Elaine A. Leventhal
Journal:  Br J Health Psychol       Date:  2002-11

9.  Assessing illness representations of chronic illness: explorations of their disease-specific nature.

Authors:  M Heijmans; D de Ridder
Journal:  J Behav Med       Date:  1998-10

10.  The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.

Authors:  R K Portenoy; H T Thaler; A B Kornblith; J M Lepore; H Friedlander-Klar; E Kiyasu; K Sobel; N Coyle; N Kemeny; L Norton
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

View more
  15 in total

1.  Assessing patients' beliefs about their cancer-related fatigue: validation of an adapted version of the Illness Perception Questionnaire.

Authors:  Maria Margareta Pertl; David Hevey; Gary Donohoe; Sonya Collier
Journal:  J Clin Psychol Med Settings       Date:  2012-09

2.  Web-based symptom management for women with recurrent ovarian cancer: a pilot randomized controlled trial of the WRITE Symptoms intervention.

Authors:  Heidi S Donovan; Sandra E Ward; Susan M Sereika; Judith E Knapp; Paula R Sherwood; Catherine M Bender; Robert P Edwards; Margaret Fields; Renee Ingel
Journal:  J Pain Symptom Manage       Date:  2013-09-07       Impact factor: 3.612

3.  Coping With Pain Severity, Distress, and Consequences in Women With Ovarian Cancer.

Authors:  Stephanie Gilbertson-White; Grace Campbell; Sandra Ward; Paula Sherwood; Heidi Donovan
Journal:  Cancer Nurs       Date:  2017 Mar/Apr       Impact factor: 2.592

4.  Symptom management in women with recurrent ovarian cancer: Do patients and clinicians agree on what symptoms are most important?

Authors:  Casey M Hay; Madeleine Courtney-Brooks; Carolyn Lefkowits; Teresa L Hagan; Robert P Edwards; Heidi S Donovan
Journal:  Gynecol Oncol       Date:  2016-08-13       Impact factor: 5.482

5.  The Self-regulation Model of Illness applied to smoking behavior in lung cancer.

Authors:  Kristine K Browning; Mary Ellen Wewers; Amy K Ferketich; Gregory A Otterson; Nancy R Reynolds
Journal:  Cancer Nurs       Date:  2009 Jul-Aug       Impact factor: 2.592

6.  Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer: an exploratory analysis.

Authors:  Heidi S Donovan; Teresa L Hagan; Grace B Campbell; Michelle M Boisen; Leah M Rosenblum; Robert P Edwards; Dana H Bovbjerg; Charles C Horn
Journal:  Support Care Cancer       Date:  2016-01-08       Impact factor: 3.603

7.  Cancer and treatment-related symptoms are associated with mobility disability in women with ovarian cancer: A cross-sectional study.

Authors:  Grace Campbell; Teresa Hagan; Stephanie Gilbertson-White; Martin Houze; Heidi Donovan
Journal:  Gynecol Oncol       Date:  2016-09-18       Impact factor: 5.482

8.  Creating Individualized Symptom Management Goals and Strategies for Cancer-Related Fatigue for Patients With Recurrent Ovarian Cancer.

Authors:  Teresa L Hagan; Janet A Arida; Susan H Hughes; Heidi S Donovan
Journal:  Cancer Nurs       Date:  2017 Jul/Aug       Impact factor: 2.592

Review 9.  Recommended patient-reported core set of symptoms and quality-of-life domains to measure in ovarian cancer treatment trials.

Authors:  Kristine A Donovan; Heidi S Donovan; David Cella; Martha E Gaines; Richard T Penson; Steven C Plaxe; Vivian E von Gruenigen; Deborah Watkins Bruner; Bryce B Reeve; Lari Wenzel
Journal:  J Natl Cancer Inst       Date:  2014-07-08       Impact factor: 13.506

10.  Opioids switching with transdermal systems in chronic cancer pain.

Authors:  C Aurilio; M C Pace; V Pota; P Sansone; M Barbarisi; E Grella; M B Passavanti
Journal:  J Exp Clin Cancer Res       Date:  2009-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.